[{"StockholdersEquityConverted_0_Q1_USD":13733000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1769000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":4877000000.0,"EarningsPerShareDiluted_1_Q1_USD":1.99,"StockholdersEquity_0_Q1_USD":13710000000.0,"Assets_0_Q1_USD":150501000000.0,"CommonStockSharesConverted_0_Q1_shares":1799637990.0,"NetIncomeLossConverted_1_Q1_USD":3529000000.0,"RevenuesConverted_1_Q1_USD":13010000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1775000000.0,"EarningsPerShareBasic_1_Q1_USD":2.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"276159000000.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20210507"}]